Compare Icl Group Ltd (ICL) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Icl Group Ltd vs Nuwellis Inc — how do they compare? Icl Group Ltd trades at $5.45 (market cap $6.94B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Icl Group Ltd is far larger — about 12785.6× Nuwellis Inc's market cap, and Icl Group Ltd pays a 3.86% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| ICL | NUWE | |
|---|---|---|
Market Cap | $6.94B | $542.80K |
Sector | Basic Materials | Technology |
52-Week High | $6.84 | $220.50 |
52-Week Low | $4.80 | $1.42 |
Enterprise Value | $9.58B | -$1.27M |
Dividend Yield | 3.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
